EMPAGLIFLOZIN for Obesity: Side Effects & Safety Data
Lose Weight Fast — The 21-Day Smoothie Diet
36 fat-burning recipes + shopping lists. Results in the first week.
There are 10 adverse event reports in the FDA FAERS database where EMPAGLIFLOZIN was used for Obesity.
Most Reported Side Effects for EMPAGLIFLOZIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diabetic ketoacidosis | 3,644 | 9.8% | 85 | 2,610 |
| Fungal infection | 1,941 | 5.2% | 7 | 94 |
| Blood glucose increased | 1,797 | 4.9% | 4 | 306 |
| Euglycaemic diabetic ketoacidosis | 1,769 | 4.8% | 59 | 1,340 |
| Weight decreased | 1,661 | 4.5% | 25 | 328 |
| Urinary tract infection | 1,439 | 3.9% | 42 | 687 |
| Ketoacidosis | 1,411 | 3.8% | 57 | 969 |
| Dizziness | 1,372 | 3.7% | 13 | 274 |
| Nausea | 1,333 | 3.6% | 20 | 594 |
| Vomiting | 1,201 | 3.2% | 49 | 769 |
| Acute kidney injury | 1,023 | 2.8% | 72 | 751 |
| Fournier's gangrene | 1,000 | 2.7% | 63 | 681 |
| Diarrhoea | 999 | 2.7% | 19 | 314 |
| Dehydration | 973 | 2.6% | 24 | 581 |
| Pollakiuria | 944 | 2.6% | 6 | 90 |
Other Indications for EMPAGLIFLOZIN
Product used for unknown indication (16,449)
Type 2 diabetes mellitus (12,176)
Diabetes mellitus (4,267)
Cardiac failure (1,338)
Type 1 diabetes mellitus (383)
Chronic kidney disease (209)
Cardiac failure chronic (172)
Cardiac failure congestive (158)
Cardiac disorder (157)
Blood glucose increased (138)
Other Drugs Used for Obesity
SEMAGLUTIDE (2,586)
LIRAGLUTIDE (1,090)
BUPROPION\NALTREXONE (726)
TIRZEPATIDE (700)
ORLISTAT (163)
PHENTERMINE (127)
DULAGLUTIDE (109)
METFORMIN (100)
PHENTERMINE\TOPIRAMATE (86)
TOPIRAMATE (86)